首页> 外国专利> METHOD FOR DIAGNOSING CHRONIC OBSTRUCTIVE AIRWAY DISEASE THROUGH BACTERIAL METAGENOME ANALYSIS

METHOD FOR DIAGNOSING CHRONIC OBSTRUCTIVE AIRWAY DISEASE THROUGH BACTERIAL METAGENOME ANALYSIS

机译:通过细菌基因组分析诊断慢性阻塞性呼吸道疾病的方法

摘要

The present invention relates to a method of diagnosing chronic obstructive airway disease such as asthma, COPD, and the like through bacterial metagenomic analysis, and more particularly, to a method of diagnosing chronic obstructive pulmonary disease and asthma by analyzing an increase or decrease in content of extracellular vesicles derived from specific bacteria through bacterial metagenomic analysis using a subject-derived sample. Extracellular vesicles secreted from bacteria present in the environment are absorbed into the human body, and thus may directly affect inflammatory responses, and it is difficult to diagnose chronic obstructive airway diseases such as asthma, COPD, and the like early before symptoms occur, and thus efficient treatment therefor is difficult. Thus, according to the present invention, a risk of developing chronic obstructive airway diseases such as asthma, COPD, and the like can be predicted through metagenomic analysis of a gene present in bacteria-derived extracellular vesicles by using a human body-derived sample, and thus the onset of chronic obstructive airway diseases can be delayed or prevented through appropriate management by early diagnosis and prediction of a risk group for chronic obstructive airway diseases, and, even after chronic obstructive airway diseases such as asthma, COPD, and the like occur, early diagnosis therefor can be implemented, thereby lowering the incidence rate of chronic obstructive airway diseases and increasing therapeutic effects.
机译:本发明涉及通过细菌宏基因组学分析诊断诸如哮喘,COPD等慢性阻塞性气道疾病的方法,更具体地,涉及通过分析含量的增加或减少来诊断慢性阻塞性肺疾病和哮喘的方法。通过使用受试者来源的样品进行细菌宏基因组分析,分析特定细菌衍生的细胞外囊泡。由环境中存在的细菌分泌的细胞外囊泡被人体吸收,因此可能直接影响炎症反应,因此在症状出现之前及早诊断出慢性阻塞性气道疾病(如哮喘,COPD等)很困难。因此,有效的治疗是困难的。因此,根据本发明,通过使用人体衍生的样品,通过对细菌衍生的细胞外囊泡中存在的基因的宏基因组分析,可以预测出发生慢性阻塞性气道疾病如哮喘,COPD等的风险,因此,可以通过早期诊断和预测慢性阻塞性呼吸道疾病的危险人群,通过适当的管理来延迟或预防慢性阻塞性呼吸道疾病的发作,甚至在发生慢性阻塞性气道疾病(例如哮喘,COPD等)之后因此,可以实现早期诊断,从而降低慢性阻塞性气道疾病的发生率并提高治疗效果。

著录项

  • 公开/公告号US2020056225A1

    专利类型

  • 公开/公告日2020-02-20

    原文格式PDF

  • 申请/专利权人 MD HEALTHCARE INC.;

    申请/专利号US201816488258

  • 发明设计人 YOON-KEUN KIM;

    申请日2018-02-23

  • 分类号C12Q1/689;

  • 国家 US

  • 入库时间 2022-08-21 11:22:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号